These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3859212)

  • 1. Role for newer beta-lactam antibiotics in treatment of osteomyelitis.
    Gentry LO
    Am J Med; 1985 Jun; 78(6A):134-9. PubMed ID: 3859212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastatin in the treatment of osteomyelitis.
    MacGregor RR; Gentry LO
    Am J Med; 1985 Jun; 78(6A):100-3. PubMed ID: 3859207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
    Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
    Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem and cilastatin in acute osteomyelitis and suppurative arthritis. Therapy in infants and children.
    Freij BJ; Kusmiesz H; Shelton S; Nelson JD
    Am J Dis Child; 1987 Mar; 141(3):335-42. PubMed ID: 3544811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of imipenem/cilastatin in the treatment of soft tissue infections.
    Marier RL
    Am J Med; 1985 Jun; 78(6A):140-4. PubMed ID: 3890534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumonia treated with imipenem/cilastatin.
    Salata RA; Gebhart RL; Palmer DL; Wade BH; Scheld WM; Groschel DH; Wenzel RP; Mandell GL; Duma RJ
    Am J Med; 1985 Jun; 78(6A):104-9. PubMed ID: 3859208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.
    Zajac BA; Fisher MA; Gibson GA; MacGregor RR
    Antimicrob Agents Chemother; 1985 May; 27(5):745-8. PubMed ID: 3860187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections.
    Diaz-Mitoma F; Harding GK; Louie TJ; Thomson M; James M; Ronald AR
    Rev Infect Dis; 1985; 7 Suppl 3():S452-7. PubMed ID: 3901207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/cilastatin: general experience in a community hospital.
    Iannini PB; Kunkel MJ; Hilton E; Iannini GM
    Am J Med; 1985 Jun; 78(6A):122-6. PubMed ID: 3859211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
    Bompard Y; Lambert T; Gantzer A; Chastel A; Voinnesson A; Aufrant C
    Pathol Biol (Paris); 1988 May; 36(5):521-4. PubMed ID: 3043351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
    Unertl K; Ruckdeschel G; Forst H; Lenhart FP
    Infection; 1986; 14 Suppl 2():S176-80. PubMed ID: 3759253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of imipenem: the first thienamycin antibiotic.
    Kropp H; Gerckens L; Sundelof JG; Kahan FM
    Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
    Brooks RG; McCabe RE; Vosti KL; Remington JS
    Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience.
    Kager L; Nord CE
    Rev Infect Dis; 1985; 7 Suppl 3():S518-21. PubMed ID: 3901215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections.
    Trumbore D; Pontzer R; Levison ME; Kaye D; Cynamon M; Liu C; Hinthorn DR; Tan JS; File TM
    Rev Infect Dis; 1985; 7 Suppl 3():S476-81. PubMed ID: 3931198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.
    Wang C; Calandra GB; Aziz MA; Brown KR
    Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.